Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab

Autor: Bouhlel, Linda, Doyen, Jérôme *, Chamorey, Emmanuel, Poudenx, Michel, Ilie, Marius, Gal, Jocelyn, Guigay, Joël, Benzaquen, Jonathan, Marquette, Charles-Hugo, Berthet, Jean-Philippe, Mouroux, Jérôme, Schiappa, Renaud, Padovani, Bernard, Hofman, Paul, Otto, Josiane
Zdroj: In Bulletin du Cancer September 2020 107(9):946-958
Databáze: ScienceDirect